Suzuki H, Ogawa M, Hironaka K, Ito K, Sunada H
Fuji Laboratory, Janssen-Kyowa Co., Ltd., Sunto-gun, Shizuoka, Japan.
Drug Dev Ind Pharm. 2001 Oct;27(9):943-9. doi: 10.1081/ddc-100107675.
Sodium deoxycholate (DCNa) is a bile salt that forms multimolecular inclusion compounds with a variety of organic substances. In this study, complex formulation of DCNa with nifedipine, a poorly water soluble drug, by grinding was investigated. The coground mixture was prepared with a vibration rod mill, and its solid state was characterized using powder X-ray diffraction, differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) spectroscopy. A laser diffraction particle size analyzer was also used to determine the particle size distribution curve in solution. When a nifedipine-DCNa (1:2 w/w) mixture coground for 30 min was dispersed into water and a pH 6.8 buffer solution, a semitransparent colloidal solution occurred immediately; 90% of the total particles formed in solution had a diameter less than 600 nm. Both powder X-ray diffraction peaks and DSC endothermic peak of nifedipine crystals were not found for the coground mixture, whereas a new exothermic peak was observed on DSC thermograms. The magnitude of this exothermic peak depended on the weight fraction of DCNa and the grinding time, indicating that nifedipine crystals changed into an amorphous state by complex formation with DCNa during the grinding process. In the FTIR spectrum of the coground mixture, the peaks of aromatic CH out-of-plane bend and dihydropyridine NH stretch of nifedipine were considerably weakened, suggesting that van der Waals interaction may be present between the drug and DCNa molecules. From these results, it is clear that the cogrinding method with DCNa is very useful for the formation of amorphous nifedipine in the solid state and the production of colloidal particles of the drug in solution.
脱氧胆酸钠(DCNa)是一种胆汁盐,可与多种有机物质形成多分子包合物。在本研究中,对DCNa与难溶性药物硝苯地平通过研磨形成的复方制剂进行了研究。使用振动棒磨机制备共研磨混合物,并通过粉末X射线衍射、差示扫描量热法(DSC)和傅里叶变换红外(FTIR)光谱对其固态进行表征。还使用激光衍射粒度分析仪测定溶液中的粒度分布曲线。当将共研磨30分钟的硝苯地平-DCNa(1:2 w/w)混合物分散到水和pH 6.8缓冲溶液中时,立即形成半透明胶体溶液;溶液中形成的总颗粒90%的直径小于600 nm。共研磨混合物未发现硝苯地平晶体的粉末X射线衍射峰和DSC吸热峰,而在DSC热谱图上观察到一个新的放热峰。该放热峰的大小取决于DCNa的重量分数和研磨时间,表明在研磨过程中硝苯地平晶体通过与DCNa形成复合物而转变为无定形状态。在共研磨混合物的FTIR光谱中,硝苯地平的芳香族CH面外弯曲峰和二氢吡啶NH伸缩峰明显减弱,表明药物与DCNa分子之间可能存在范德华相互作用。从这些结果可以清楚地看出,DCNa共研磨法对于固态无定形硝苯地平的形成以及溶液中药物胶体颗粒的制备非常有用。